Stuttgart, 30 November 2021 – The Robert Bosch Stiftung is adjusting its organizational structure in line with its new focuses. It intends to pursue charitable funding activities in an even more targeted and efficient manner with fewer staff members. By December 2022, the foundation intends to reduce the number of its employees by around 20 percent. This will be done in a socially responsible manner and through staff attrition, as the management announced today to employee representatives and staff. “The goal is to realign our content and structure to social and political developments, and changes in global philanthropy,” said CEO Sandra Breka.
In 2019 to 2020, the Robert Bosch Stiftung, in a far-reaching strategic reorientation, refocused its work on three funding areas: health, education, and global issues. It reduced the number of its thematic areas from 34 to ten. This realignment has significantly changed the nature of its funding. In view of the size and complexity of societal challenges, the Robert Bosch Stiftung, like other German and international foundations, is now focusing more strongly on collaborative approaches.
Overall, the foundations program work is now significantly less operational and more grant-making than before the strategic reorientation,” said CEO Dr. Bernhard Straub. In the areas of global issues and health, collaborations and third-party funding have increased, as has participation in alliances with other funders. “We are pooling resources and expertise with other players, thereby increasing the impact of our work,” Straub emphasized.
The foundation continues its institutional support of facilities such as the Robert Bosch Hospital and the Institute for Clinical Pharmacology in Stuttgart.
Two new reorganizations
This year, the Robert Bosch Stiftung kicked off two new reorganizations. In July, it integrated its previous subsidiary, Die Deutsche Schulakademie (The German School Academy), into the foundation. It also founded the Bosch Health Campus (BHC), which is now where the foundation brings together all its healthcare activities and resources. These include the Robert Bosch Hospital, the Institute for Clinical Pharmacology, the Robert Bosch Center for Tumor Diseases, the Irmgard Bosch Education Center, and the Robert Bosch Center for Innovative Health, which emerged from the foundation's health funding area.
In 2020, the Robert Bosch Stiftung invested a total of 80 million euros in its funding activities.